Swiss Re Insurance-Linked Fund Management

Xactanalysis Insights and PCS

Survey on the re/insurance implications of Covid-19 coronavirus pandemic


Alongside our sister publication Reinsurance News, we’ve launched a new survey for the insurance, reinsurance and insurance-linked securities (ILS) industry, asking for your opinion on the market implications of the Covid-19 coronavirus pandemic.

Survey imageWe are witnessing history unfolding as a global industry that is profoundly connected and affected – personally and professionally – by the COVID-19 coronavirus outbreak.

This outbreak raises many questions and will potentially shape the world’s markets and economy for generations to come.

So it’s useful to understand the potential insurance and reinsurance market implications from your point of view, those working in it. Answer our survey here.

We’re interested in your thoughts on the initial implications of the coronavirus pandemic for insurance and reinsurance market participants.

This brief survey is intended to capture a snapshot of this historic moment, create useful data to inform actions, and take the pulse of the market at this time.

We wish you, your families and colleagues all the best at this challenging time!

Please respond to our survey here.

Our global readership reached almost 200,000 individuals across Reinsurance News & Artemis in Feb 2020. Please get in touch to work with us on a sponsored survey to gauge the market’s opinion, or to discuss advertising options.

Read all of our Covid-19 coronavirus pandemic news here.

Register today for ILS NYC 2023, our next insurance-linked securities (ILS) market conference. Held in New York City, February 10th, 2023.

Artemis London 2022 - Insurance-linked securities conference in London

Get a ticket soon to ensure you can attend. Secure your place at the event here!

Print Friendly, PDF & Email

Artemis Newsletters and Email Alerts

Receive a regular weekly email newsletter update containing all the top news stories, deals and event information

  • This field is for validation purposes and should be left unchanged.

Receive alert notifications by email for every article from Artemis as it gets published.